LeMaitre Vascular Inc (OQ:LMAT)
Business Focus: Advanced Medical Equipment & Technology
| Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 63 2nd Ave BURLINGTON MA 01803-4413 |
| Tel: | N/A |
| Website: | https://www.lemaitre.com |
| IR: | See website |
| Key People | ||
| George W. LeMaitre Chairman of the Board, Chief Executive Officer | Chance Kriesel Vice President - Sales, The Americas | David Brian Roberts President, Director |
| Joseph P. Pellegrino Chief Financial Officer, Director | Ryan H. Connelly Senior Vice President - Advanced Manufacturing Engineering | Andrew Hodgkinson Senior Vice President - Clinical, Regulatory, Quality Affairs |
| Trent G. Kamke Senior Vice President - Operations | Stephane Maier Senior Vice President, EMEA Operations | Giovannella Deiure Vice President - Sales, Southern Europe | Helen Goulding Vice President - Sales, Northern Europe |
| Business Overview |
| LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company's principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, LeMaitre Vascular Inc revenues increased 20% to $193.5M. Net income increased 46% to $30.1M. Revenues reflect United States segment increase of 18% to $117.8M, Canada segment increase of 29% to $10.8M. Net income benefited from Restructuring decrease of 84% to $485K (expense), Interest Income increase from $986K to $3.1M (income). Dividend per share increased from $0.49 to $0.55. |
| Employees: | 614 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $1,304M as of Dec 31, 2023 |
| Annual revenue (TTM): | $193.48M as of Dec 31, 2023 |
| EBITDA (TTM): | $46.71M as of Dec 31, 2023 |
| Net annual income (TTM): | $30.11M as of Dec 31, 2023 |
| Free cash flow (TTM): | $17.04M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 22,445,999 as of Apr 5, 2024 |
| Index Membership: | S&P 600 Small Cap |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.